MedPath

Corneal Cross-Linking Comparing Variables

Phase 3
Conditions
Unstable Corneas
Interventions
Drug: Epithelium-On Riboflavin
Drug: Epithelium-Off Riboflavin
Device: UV Light - Continuous Beam
Device: UV Pulsed Beam
Registration Number
NCT02095730
Lead Sponsor
Crowd Health Research, LTD
Brief Summary

The purpose of this study is to evaluate the Safety and Efficacy of Corneal Cross Linking in a Continuous Beam versus Pulsed Treatments across epithelium on and epithelium off surfaces.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
500
Inclusion Criteria

Not provided

Exclusion Criteria
  • Eyes classified as either normal, atypical normal,
  • Corneal pachymetry ≤ 350 microns at the thinnest point measured by Orbscan, Pentacam, or ultrasound in the eye to be treated
  • A history of chemical injury or delayed epithelial healing in the eye to be treated.
  • A known sensitivity to study medications
  • Patients with significant nystagmus or any other condition that would prevent a steady gaze during the treatment
  • Inability to cooperate with diagnostic tests.
  • Patients with a current condition that, in the investigator's opinion, would interfere with or prolong epithelial healing.
  • Taking Vitamin C (ascorbic acid) supplements within 1 week of the cross-linking treatment.
  • Patients who are unable to remain comfortable and stable, and tolerate a lid speculum for the appointed period of time for the procedure.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Epi-On ContinuousEpithelium-On RiboflavinContinuous beam of UV light treating cornea with surface epithelium present
Epi-On ContinuousUV Light - Continuous BeamContinuous beam of UV light treating cornea with surface epithelium present
Epi-Off ContinuousEpithelium-Off RiboflavinContinuous beam of UV light treating cornea without surface epithelium present
Epi-Off ContinuousUV Light - Continuous BeamContinuous beam of UV light treating cornea without surface epithelium present
Epi-On PulsedEpithelium-On RiboflavinPulsed beam of UV light treating cornea with surface epithelium present
Epi-On PulsedUV Pulsed BeamPulsed beam of UV light treating cornea with surface epithelium present
Epi-Off PulsedEpithelium-Off RiboflavinPulsed beam of UV light treating cornea without surface epithelium present
Epi-Off PulsedUV Pulsed BeamPulsed beam of UV light treating cornea without surface epithelium present
Primary Outcome Measures
NameTimeMethod
Visual Acuity2 years

Uncorrected visual acuity

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (16)

LaserVue Eye

🇺🇸

Santa Rosa, California, United States

Icon Lasik

🇺🇸

Denver, Colorado, United States

Gulani Vision Institute

🇺🇸

Jacksonville, Florida, United States

Eye Consultants of Atlanta

🇺🇸

Atlanta, Georgia, United States

Midwest Center for Sight

🇺🇸

Des Plaines, Illinois, United States

Bond Eye Associates

🇺🇸

Pekin, Illinois, United States

Discover Vision Center

🇺🇸

Leawood, Kansas, United States

Southern Eye Center

🇺🇸

Hattiesburg, Mississippi, United States

Mercy Clinic Eye Specialists

🇺🇸

Springfield, Missouri, United States

LASIK of Nevada

🇺🇸

Las Vegas, Nevada, United States

Scroll for more (6 remaining)
LaserVue Eye
🇺🇸Santa Rosa, California, United States
Jay Bansal, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.